RESMED INC — Director's Dealing 2021

Dec 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2021-11-30

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-30	ResMed Common Stock	G	3880	—	Disposed	5090	Indirect
2021-11-30	ResMed Common Stock	G	3880	—	Acquired	3880	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	405229	Direct

Footnotes

F1: Gift of shares transferred to The Lisette and Michael Farrell Foundation, Mr. Farrell retains dispositive power over remaining shares.

F2: Gift of shares transferred from The Lisette and Michael Farrell Family Trust, Mr. Farrell retains dispositive power over the gifted shares.